MetaVia (MTVA) Cash & Equivalents (2015 - 2026)
MetaVia's Cash & Equivalents came in at $12.63 million for Q2 2026, down 28.2% from $17.6 million a year earlier.
Powered by 
Analysis
MetaVia (MTVA) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, MetaVia's Cash & Equivalents was $10.28 million, down 35.8% from FY2024.
- Cash & Equivalents has declined in each of the last three years, though with a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $16.02 million in FY2024 (-28.6%), $22.44 million in FY2023 (-32.8%), $33.36 million in FY2022 (+103.6%) and $16.39 million in FY2021 (+62.4%).
- The five-year range for quarterly Cash & Equivalents is $6.4 million (Q3 2022) to $33.36 million (Q4 2022).
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2023 (growth of 303.7%), and the weakest in Q1 2024 (a decline of 48.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | MetaVia | 10.32 Mn | -44.49 Mn | - | 12.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.63 Mn |
| Dec 31, 2025 | 10.28 Mn |
| Sep 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 17.60 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 16.02 Mn |
| Sep 30, 2024 | 21.70 Mn |
| Jun 30, 2024 | 27.93 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 22.44 Mn |
| Sep 30, 2023 | 25.84 Mn |
| Jun 30, 2023 | 28.70 Mn |
| Mar 31, 2023 | 30.81 Mn |
| Dec 31, 2022 | 33.36 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 8.85 Mn |
| Mar 31, 2022 | 11.60 Mn |
| Dec 31, 2021 | 16.39 Mn |
| Sep 30, 2021 | 7.00 Mn |
| Jun 30, 2021 | 9.51 Mn |
API Access
MetaVia Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MTVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MTVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MTVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();